These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 26137264
1. Nedaplatin- versus cisplatin-based chemotherapy in the survival time of patients with non-small cell lung cancer. Shan J, Xiong Y, Wang D, Xu M, Yang YI, Gong K, Yang Z, Wang GE, Yang X. Mol Clin Oncol; 2015 May; 3(3):543-549. PubMed ID: 26137264 [Abstract] [Full Text] [Related]
2. [Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors]. Zhang P, Feng FY, Wu LY, Hu Y, Liu JW, Gao YJ, Guan XQ, Nan KJ, Suo AL, Wang XW, Zhang MH, Zhang WD, Li CW, Zhang Y, Zhao JB. Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):230-4. PubMed ID: 16875614 [Abstract] [Full Text] [Related]
3. Nedaplatin reduces multidrug resistance of non-small cell lung cancer by downregulating the expression of long non-coding RNA MVIH. Jing C, Wang Z, Lou R, Wu J, Shi C, Chen D, Ma R, Liu S, Cao H, Feng J. J Cancer; 2020 Mar; 11(3):559-569. PubMed ID: 31942179 [Abstract] [Full Text] [Related]
4. [Comparison of treatment efficacy of the second and the third generations of chemoradiotherapy regimens containing platinum on advanced non-small cell lung cancer]. Wang YM, Guo LJ, Li LS, Li P, Zheng J, Li L. Ai Zheng; 2005 Dec; 24(12):1514-7. PubMed ID: 16351804 [Abstract] [Full Text] [Related]
5. Nedaplatin sensitization of cisplatin-resistant human non-small cell lung cancer cells. Wang H, Zhu X, Huang J, Chen P, Han S, Yan X. Oncol Lett; 2016 Apr; 11(4):2566-2572. PubMed ID: 27073518 [Abstract] [Full Text] [Related]
6. Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer. Oshita F, Yamada K, Kato Y, Ikehara M, Noda K, Tanaka G, Nomura I, Suzuki R, Saito H. Cancer Chemother Pharmacol; 2003 Jul; 52(1):73-8. PubMed ID: 12750839 [Abstract] [Full Text] [Related]
8. Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial. Tang LQ, Chen DP, Guo L, Mo HY, Huang Y, Guo SS, Qi B, Tang QN, Wang P, Li XY, Li JB, Liu Q, Gao YH, Xie FY, Liu LT, Li Y, Liu SL, Xie HJ, Liang YJ, Sun XS, Yan JJ, Wu YS, Luo DH, Huang PY, Xiang YQ, Sun R, Chen MY, Lv X, Wang L, Xia WX, Zhao C, Cao KJ, Qian CN, Guo X, Hong MH, Nie ZQ, Chen QY, Mai HQ. Lancet Oncol; 2018 Apr; 19(4):461-473. PubMed ID: 29501366 [Abstract] [Full Text] [Related]
9. [Clinical study of navelbine combined with cisplatin in the treatment of advanced non-small cell lung cancer]. He Y. Zhongguo Fei Ai Za Zhi; 2004 Dec 20; 7(6):517-9. PubMed ID: 21251412 [Abstract] [Full Text] [Related]
11. Comparative effectiveness study of single high-dose cisplatin with fractionated doses cisplatin in first-line therapy for treatment-naive Chinese patients with advanced non-small-cell lung cancer. Li X, Zhao X, Abbas M, Wang L, Li C, Liu S, Feng J, Shi M. Curr Probl Cancer; 2019 Dec 20; 43(6):100466. PubMed ID: 30777344 [Abstract] [Full Text] [Related]
12. Concurrent chemoradiotherapy with weekly nedaplatin versus radiotherapy alone in elderly patients with non-small-cell lung cancer. Chen F, Hu P, Liang N, Xie J, Yu S, Tian T, Zhang J, Deng G, Zhang J. Clin Transl Oncol; 2018 Mar 20; 20(3):294-301. PubMed ID: 28741074 [Abstract] [Full Text] [Related]
13. Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial. Li L, Zhuang Q, Cao Z, Yin R, Zhu Y, Zhu L, Xie X, Zhang Y, Li L, Wu Q, Zheng J, Zhou Q, Li X, Wu L, Feng Y, Wang C. Oncol Lett; 2018 Mar 20; 15(3):3646-3652. PubMed ID: 29467885 [Abstract] [Full Text] [Related]
14. Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data. Rossi A, Chiodini P, Sun JM, O'Brien ME, von Plessen C, Barata F, Park K, Popat S, Bergman B, Parente B, Gallo C, Gridelli C, Perrone F, Di Maio M. Lancet Oncol; 2014 Oct 20; 15(11):1254-62. PubMed ID: 25232001 [Abstract] [Full Text] [Related]
15. Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer. Murakami S, Saito H, Kondo T, Ito H, Oshita F, Yamada K. Cancer Chemother Pharmacol; 2018 Jan 20; 81(1):81-87. PubMed ID: 29116379 [Abstract] [Full Text] [Related]
16. [Induction chemotherapy with docetaxel plus cisplatin (TP regimen) followed by concurrent chemoradiotherapy with TP regimen versus cisplatin in treating locally advanced nasopharyngeal carcinoma]. Xie FY, Zou GR, Hu WH, Qi SN, Peng M, Li JS. Ai Zheng; 2009 Mar 20; 28(3):279-85. PubMed ID: 19619443 [Abstract] [Full Text] [Related]
17. [Augmented antitumor activity in combination chemotherapy of nedaplatin with etoposide]. Uchida N, Kasai H, Takeda Y, Maekawa R, Sugita K, Yoshioka T. Gan To Kagaku Ryoho; 1998 Jan 20; 25(1):79-87. PubMed ID: 9464333 [Abstract] [Full Text] [Related]
18. [Clinical report of combined chemotherapy with gemcitabine plus cisplatin as first-line treatment to 79 cases of advanced non-small cell lung cancer]. Lin L, Hao X, Li J, Wang Z, Wang Y, Wang H, Hu X, Zhang X. Zhongguo Fei Ai Za Zhi; 2007 Dec 20; 10(6):513-9. PubMed ID: 21129311 [Abstract] [Full Text] [Related]
19. Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: a retrospective study. Yamashita H, Nakagawa K, Tago M, Igaki H, Nakamura N, Shiraishi K, Sasano N, Ohtomo K. Dis Esophagus; 2006 Dec 20; 19(1):15-9. PubMed ID: 16364038 [Abstract] [Full Text] [Related]
20. [Clinical research on combined chemotherapy of vinorelbine and cisplatin in the treatment of non-small cell lung cancer]. Xu L, Zhu Y, You Y, Shi H, Liu Z, Tang J, Zhang X, Meng Q, Wu Y, Guo L. Zhongguo Fei Ai Za Zhi; 2003 Oct 20; 6(5):381-5. PubMed ID: 21306685 [Abstract] [Full Text] [Related] Page: [Next] [New Search]